Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to evaluate the outcomes of patients undergoing total knee
replacement with two different methods of local pain control:shots of liposomal bupivacaine,
a long acting anesthetic, directly into the knee during surgery or anesthetic delivered
continuously to the adductor canal to provide long term pain relief. The goal is to try to
find a standard protocol that provides the greatest pain relief for patients undergoing total
knee replacement.
Phase:
Phase 4
Details
Lead Sponsor:
Texas Orthopaedics, Sports and Rehabilitation Associates